Antiplatelet Effect of Low Doses of Aspirin Taken Every 12 Hours in Patients Undergoing Coronary Artery Bypass Graft and/or Aortic Valve Surgery

NCT01466452 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

99

Enrollment

OTHER

Sponsor class

Conditions

Coronary Arteriosclerosis

Interventions

DRUG: Aspirin
DRUG: Aspirin
DRUG: Aspirin

Sponsor

Centro Cardiologico Monzino

Collaborators

[object Object]
[object Object]